Загрузка...
Current status of immunological approaches for the treatment of prostate cancer
PURPOSE OF REVIEW: The recent Food and Drug Administration approval of sipuleucel-T for metastatic castration-resistant prostate cancer and of the anticytotoxic T-lymphocyte antigen 4 antibody (Ipilimumab) for metastatic melanoma has led to a renewed interest in immunotherapy for prostate and other...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444809/ https://ncbi.nlm.nih.gov/pubmed/22328018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOU.0b013e3283519ad5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|